BridgeBio Pharma, Inc.
2019 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 151,012 | 0.1% | 1,975,315 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 81,678 | 0.1% | 1,891,578 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 65,260 | 0.1% | 1,887,763 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 51,746 | 0.0% | 1,885,794 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 39,010 | 0.0% | 1,532,224 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 38,881 | 0.0% | 1,534,972 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 33,787 | 0.0% | 1,092,724 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 30,041 | 0.0% | 744,132 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 17,552 | 0.0% | 665,604 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 4,228 | 0.0% | 245,791 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 735 | 0.0% | 44,310 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 335 | 0.0% | 43,902 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 427 | 0.0% | 43,005 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 398 | 0.0% | 43,798 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 459 | 0.0% | 45,184 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 912 | 0.0% | 54,664 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 2,636 | 0.0% | 56,236 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 3,745 | 0.0% | 61,436 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 3,380 | 0.0% | 54,873 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 3,172 | 0.0% | 44,603 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 1,621 | 0.0% | 43,213 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 1,446 | 0.0% | 44,367 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 1,380 | 0.0% | 47,602 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 561 | 0.0% | 16,008 | 12/31/2019 |